摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cyclopentan-1,2,4-tricarbonsaeure | 35665-83-9

中文名称
——
中文别名
——
英文名称
Cyclopentan-1,2,4-tricarbonsaeure
英文别名
cyclopentane-1,2,4-tricarboxylic acid;1,2,4-cyclopentanetricarboxylic acid
Cyclopentan-1,2,4-tricarbonsaeure化学式
CAS
35665-83-9
化学式
C8H10O6
mdl
——
分子量
202.164
InChiKey
XIECTETUPIYSLZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    112
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Cyclopentan-1,2,4-tricarbonsaeure乙酸酐 作用下, 生成 cyclopentane-1,2,4-tricarboxylic acid-1,2-anhydride
    参考文献:
    名称:
    Bottomley; Perkin jun., Journal of the Chemical Society, 1900, vol. 77, p. 304
    摘要:
    DOI:
  • 作为产物:
    描述:
    cyclopentane-1,1,2,4,4-pentacarboxylic acid pentaethyl ester 在 盐酸 作用下, 生成 Cyclopentan-1,2,4-tricarbonsaeure
    参考文献:
    名称:
    Lennon; Perkin, Journal of the Chemical Society, 1928, p. 1524
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] PHARMACEUTICAL COMPOSITIONS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES
    申请人:GENZYME CORP
    公开号:WO2009154747A1
    公开(公告)日:2009-12-23
    This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceutically acceptable composition includes, for example, crosslinked polyamine particles, or pharmaceutically acceptable salts thereof, having a particle size distribution wherein greater than 10 vol.% of the particles have a particle size greater than 500 μm.
    这项发明涉及交联胺含有聚合物用于结合化合物或离子,更具体地涉及用于结合化合物或离子的药用可接受组合物,其中包括交联胺含有聚合物。药用可接受组合物包括例如交联聚胺颗粒或其药用可接受盐,具有粒径分布,其中大于10体积%的颗粒具有大于500μm的粒径。
  • Reactive Extraction of Free Organic Acids from the Ammonium Salts Thereof
    申请人:Kobler Christoph
    公开号:US20100210871A1
    公开(公告)日:2010-08-19
    The invention relates to a process for converting ammonium salts of organic acids to the particular free organic acid, wherein an aqueous solution of the ammonium salt is contacted with an organic extractant and the salt is dissociated at temperatures and pressures at which the aqueous solution and the extractant are in the liquid state, and a stripping medium or entraining gas is introduced in order to remove NH 3 from the aqueous solution and transfer at least a portion of the free organic acid formed to the organic extractant. The invention described here thus provides an improved process for releasing an organic acid, preferably a carboxylic, sulphonic or phosphonic acid, especially an alpha-hydroxycarboxylic acid or beta-hydroxycarboxylic acid, from the ammonium salt thereof by release and removal of ammonia and simultaneous extraction of the acid released with a suitable extractant from the aqueous phase. This process corresponds to a reactive extraction. The reactive extraction of an organic acid from the aqueous ammonium salt solution thereof can be improved significantly by the use of a stripping medium or entraining gas, for example nitrogen, air, steam or inert gases, for example argon. The ammonia released is removed from the aqueous solution by the continuous gas stream and can be fed back into a production process. The free acid can be obtained from the extractant by a process such as distillation, rectification, crystallization, re-extraction, chromatography, adsorption, or by a membrane process.
    该发明涉及一种将有机酸铵盐转化为特定游离有机酸的过程,其中将铵盐的水溶液与有机萃取剂接触,并在水溶液和萃取剂处于液态的温度和压力下解离盐,并引入脱氨介质或夹带气体,以从水溶液中去除NH3并将形成的至少一部分游离有机酸转移到有机萃取剂中。该发明描述了一种改进的释放有机酸的过程,尤其是从铵盐中释放和去除氨并同时用适当的萃取剂从水相中萃取释放的酸,优选为羧酸、磺酸或膦酸,特别是α-羟基羧酸或β-羟基羧酸。这个过程对应于反应性萃取。通过使用脱氨介质或夹带气体(例如氮气、空气、蒸汽或惰性气体,例如氩气),可以显著改善从水溶液中的有机酸铵盐溶液中反应性萃取有机酸的过程。释放的氨由连续气流从水溶液中去除,并可以回馈到生产过程中。游离酸可以通过蒸馏、精馏、结晶、再萃取、色谱、吸附或膜过程等过程从萃取剂中获得。
  • PROCESS FOR PRODUCING TRICARBOXYLIC ACID TRIS (ALKYL-SUBSTITUTED CYCLOHEXYLAMIDE)
    申请人:Kitagawa Sachio
    公开号:US20090069599A1
    公开(公告)日:2009-03-12
    Disclosed are, for example, a process for producing a tricarboxylic acid tris(alkyl-substituted cyclohexylamide), the process comprising subjecting a tricarboxylic acid and an alkyl-substituted cyclohexylamine to an amidation reaction, either (a) in the presence of a boric acid compound and a phenol compound or (b) in the presence of a boric acid ester obtained by the dehydration condensation of a boric acid compound and a phenol compound, and optionally purifying the resulting crude reaction product.
    例如,本发明公开了一种生产三羧酸三(烷基取代的环己基)酰胺的方法,该方法包括将三羧酸和烷基取代的环己基胺置于酰胺反应中,(a)在硼酸化合物和酚化合物的存在下或(b)在通过脱水缩合一种硼酸化合物和一种酚化合物所得的硼酸酯的存在下进行反应,并可选择性地纯化所得的粗反应产物。
  • Photosensitive Resin Composition and Color Filter Prepared Using the Same
    申请人:Cheil Industries Inc.
    公开号:US20150028271A1
    公开(公告)日:2015-01-29
    The present invention relates to a compound represented by Formula 1, wherein in Formula 1, each of R 1 to R 7 is the same as defined in the specification, a photosensitive resin composition comprising the same, and a color filter prepared using the same. The color filter can realize high contrast and high brightness.
    本发明涉及一种由公式1表示的化合物,其中在公式1中,R1至R7的定义与说明书中的相同,包括该化合物的光敏树脂组合物以及使用该组合物制备的彩色滤光片。该彩色滤光片能够实现高对比度和高亮度。
  • Method of bonding
    申请人:CIBA-GEIGY AG
    公开号:EP0273012A2
    公开(公告)日:1988-06-29
    A method of bonding together two surfaces, at least one of which is gelatinous, comprises (i) sandwiching between, and in contact with, the surfaces an adhesive composition comprising a polymerisable carboxylic acid having at least one polymerisable acrylic group, and (ii) subjecting the adhesive composition to polymerising conditions therefor until it is polymerised. The bonding method is particularly suitable for bonding holograms to security cards.
    一种将两个表面粘合在一起的方法,其中至少有一个表面是胶状的,该方法包括 (i) 将含有可聚合羧酸的粘合剂组合物夹在两个表面之间并与之接触,该粘合剂 组合物含有至少一个可聚合丙烯酸基团,和 (ii) 将粘合剂组合物置于聚合条件下,直至其聚合。 这种粘合方法特别适用于将全息图粘合到防伪卡上。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物